EXCLUSIVE: A bipartisan group of more than 50 lawmakers is urging the Trump administration not to finalize a proposed Medicare policy tied to the Biden-era drug price negotiation program, arguing it could discourage development of improved cancer treatments.In a Sept. 21 letter obtained by Fox News Digital, the lawmakers called on Centers for Medicare & Medicaid Services (CMS) Administrator Dr. Mehmet Oz to remove the agency's proposed fixed-dose combination policy from its final rule implementing Medicare's Drug Price Negotiation Program.The Medicare Drug Price Negotiation Program was cre...
Trump CMS faces bipartisan pushback over Medicare proposal tied to Biden-era drug pricing law
HALO Newsroom
Sep 29, 2026 • 3 weeks ago
HALO Observer Insight
An independent HALO consumer takeaway — for costs, wellness, or policy context — will appear here automatically for this story. HALO adds this original editorial insight to every syndicated report before publication.
Contributors
Wayne G Fraser
HALO Contributor
Insurance Broker
Insurance Industry
State
Georgia, North Carolina, South Carolina
NPN
17934945